Heligenics has generated a MEGA-Map for variants in the drug target and produced a comprehensive clinical-decision tree (Fig. 1). A biopsy can be sequenced for the HER2 gene, guiding treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback